These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 35264458)

  • 1. T Cell-Specific Deletion of TRAIL Receptor Reveals Its Critical Role for Regulating Pathologic T Cell Activation and Disease Induction in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Chu CL; Hsu CL; Pan MH; Liao HJ; Wu CS; Hsu PN
    J Immunol; 2022 Apr; 208(7):1534-1544. PubMed ID: 35264458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.
    Dadey RE; Grebinoski S; Zhang Q; Brunazzi EA; Burton A; Workman CJ; Vignali DAA
    Immunohorizons; 2021 Jan; 5(1):48-58. PubMed ID: 33483333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway.
    Chyuan IT; Tsai HF; Wu CS; Hsu PN
    Mucosal Immunol; 2019 Jul; 12(4):980-989. PubMed ID: 31076664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis.
    Chyuan IT; Tsai HF; Liao HJ; Wu CS; Hsu PN
    Cell Mol Immunol; 2018 Sep; 15(9):846-857. PubMed ID: 28392572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
    Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
    J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
    Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
    J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
    Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
    Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.
    Cretney E; McQualter JL; Kayagaki N; Yagita H; Bernard CC; Grewal IS; Ashkenazi A; Smyth MJ
    Immunol Cell Biol; 2005 Oct; 83(5):511-9. PubMed ID: 16174101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.
    Prinz-Hadad H; Mizrachi T; Irony-Tur-Sinai M; Prigozhina TB; Aronin A; Brenner T; Dranitzki-Elhalel M
    J Neuroinflammation; 2013 Mar; 10():36. PubMed ID: 23497038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.
    Aktas O; Smorodchenko A; Brocke S; Infante-Duarte C; Schulze Topphoff U; Vogt J; Prozorovski T; Meier S; Osmanova V; Pohl E; Bechmann I; Nitsch R; Zipp F
    Neuron; 2005 May; 46(3):421-32. PubMed ID: 15882642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
    J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
    Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
    J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
    Bedoui S; Miyake S; Lin Y; Miyamoto K; Oki S; Kawamura N; Beck-Sickinger A; von Hörsten S; Yamamura T
    J Immunol; 2003 Oct; 171(7):3451-8. PubMed ID: 14500640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special AT-rich sequence binding protein 1 is required for maintenance of T cell receptor responsiveness and development of experimental autoimmune encephalomyelitis.
    Akiba Y; Kuwabara T; Mukozu T; Mikami T; Kondo M
    Microbiol Immunol; 2018 Apr; 62(4):255-268. PubMed ID: 29388727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation.
    Lehnert C; Weiswange M; Jeremias I; Bayer C; Grunert M; Debatin KM; Strauss G
    J Immunol; 2014 Oct; 193(8):4021-31. PubMed ID: 25217163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.
    Razmara M; Hilliard B; Ziarani AK; Murali R; Yellayi S; Ghazanfar M; Chen YH; Tykocinski ML
    Am J Pathol; 2009 Feb; 174(2):460-74. PubMed ID: 19147815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.
    Engelmann S; Togni M; Thielitz A; Reichardt P; Kliche S; Reinhold D; Schraven B; Reinhold A
    J Immunol; 2013 Nov; 191(10):4950-9. PubMed ID: 24101551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.
    Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED
    Front Immunol; 2018; 9():50. PubMed ID: 29422898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell upregulation of programmed death ligand-1 via DNA demethylation inhibits experimental autoimmune encephalomyelitis.
    Chang CB; Lee SP; Chen WM; Wang CM; Song YC; Chan MW; Wu SF
    J Autoimmun; 2020 Feb; 107():102362. PubMed ID: 31787479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.